Markets:

Overview

News

Currencies

International

Treasuries

MAIA Biotechnology, Inc. Common Stock (NY:MAIA)

1.420 -0.150 (-9.55%)

Streaming Delayed Price Updated: 2:14 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about MAIA Biotechnology, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 Next >

MAIA Biotechnology Announces Share Repurchase Program

September 28, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports Second Quarter 2023 Financial Results and Provides Updates for THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer

August 08, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports Updates on Disease Control Rates for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer

July 11, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports Updates on Preliminary Survival Data for THIO-101 Phase 2 Trial for Advanced Non-Small Cell Lung Cancer

July 10, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

July 05, 2023

Via Benzinga

7 Up-and-Coming Stocks to Buy for the Next Decade ↗

June 29, 2023

While less-established enterprises are best left for speculators, these up-and-coming stocks to buy also feature huge upside potential.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 20, 2023

Gainers

Via Benzinga

MAIA Biotechnology Announces Updates in Enrollment in Phase II Clinical Trial: THIO-101 Has Enrolled 29 Patients

June 20, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Files Second Patent For New Telomere-Targeting Molecules Program

June 07, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports First Quarter 2023 Financial Results and Provides Corporate Update

May 08, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

TRACON Pharmaceuticals And 2 Other Stocks Under $3 Insiders Are Aggressively Buying ↗

May 01, 2023

The Dow Jones closed higher by more than 250 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

MAIA Biotechnology, Inc. Announces Closing of Public Offering

April 27, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 25, 2023

Gainers

Via Benzinga

Nasdaq Down 50 Points; US Home Price Index Rises In February ↗

April 25, 2023

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.01% to 33,872.34 while the...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 25, 2023

Via Benzinga

Why Aaron's Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

April 25, 2023

Gainers ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 36.7% to $1.49 in pre-market trading after dropping around 17% on Monday. ZeroFox completed the acquisition of LookingGlass Cyber Solutions, Inc.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 25, 2023

It's time for another dive into the biggest pre-market stock movers as we check out the latest news worth watching on Tuesday!

Via InvestorPlace

MAIA Biotechnology, Inc. Announces Pricing of Public Offering

April 24, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

GeoVax Labs And 2 Other Penny Stocks Insiders Are Aggressively Buying ↗

April 24, 2023

The Dow Jones closed slighty higher on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...

Via Benzinga

MAIA Biotechnology Reports Preliminary Survival Data in Part A of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer

April 20, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

JOANN And 3 Other Stocks Under $4 Insiders Are Aggressively Buying ↗

April 19, 2023

The Dow Jones closed slightly lower on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny...

Via Benzinga

MAIA Biotechnology Announces Excellent Efficacy of THIO in Liver Cancer Models

April 18, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology to Present at AACR Annual Meeting 2023

April 12, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Touts Positive Data From Healthy Volunteer Study Of Potential Lung Cancer Candidate ↗

April 11, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 11, 2023

Via Benzinga

MAIA Biotechnology Reports Positive Topline Data from Part A Safety Lead-In of THIO-101 Phase 2 Trial for Non-Small Cell Lung Cancer

April 11, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology Reports Full Year 2022 Financial Results and Provides Corporate Update

March 24, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

MAIA Biotechnology And 2 Other Stocks Under $5 Insiders Are Aggressively Buying ↗

March 23, 2023

The Dow Jones closed lower by more than 500 points on Wednesday following Fed’s rate decision. When insiders purchase or sell shares, it indicates their confidence or concern around the company's...

Via Benzinga

MAIA Biotechnology Announces No Exposure to Silicon Valley Bank

March 13, 2023

From MAIA Biotechnology, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

March 21, 2023

On Tuesday, 74 companies achieved new lows for the year.

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.